In developed nations, endometrial cancer is the most prevalent cancer that affects women. Endometrial cancer was the third most frequent gynaecological malignancy at BIACH & RI, with 636 cases (11.5%) overall throughout the study period. The Middle and high-income groups had the highest incidence i.e. 70.28%. The majority of cases, 233 (36.63%), occurred in the age group 51–60 years, followed by 204 (32.07%) in the 61–70 age group. The mean age at endometrial malignancy diagnosis was 58.19±10.86. A stage I diagnosis was made in 35.4% of endometrial cancer cases, a stage IV diagnosis in 35.1%, a stage III diagnosis in 17.7%, and a stage II diagnosis in 11.84%. The prevalence of diabetes, hypertension, and hypothyroidism was around 23%, 39%, and 11%, respectively, in patients with endometrial cancer. Menopause was experienced by 56.4% of women between the ages of 41 and 50 and 30.33% of women between the ages of 51 and 60. Postmenopausal bleeding was found to be the main symptom in 346 instances. The illness has spread to various body parts in 136 patients. In total, nine hospital deaths have been reported. Keywords: Endometrial cancer, epidemiology, menopausal age, stage of diagnosis, postmenopausal bleeding.
×
How to Cite This Article
Vancouver
K N, C M, K S, RT S. Epidemiology of Endometrial Cancer at a Tertiary Cancer Hospital, Hyderabad [Internet]. Int J Recent Innov Med Clin Res. 2022 [cited 2025 Sep 27];4(3):106-111. Available from: https://doi.org/10.18231/j.ijrimcr.2022.026
APA
K, N., C, M., K, S., RT, S. (2022). Epidemiology of Endometrial Cancer at a Tertiary Cancer Hospital, Hyderabad. Int J Recent Innov Med Clin Res, 4(3), 106-111. https://doi.org/10.18231/j.ijrimcr.2022.026
MLA
K, Nirmala, C, Manjulatha, K, Suseela, RT, Subramaniyeshwar. "Epidemiology of Endometrial Cancer at a Tertiary Cancer Hospital, Hyderabad." Int J Recent Innov Med Clin Res, vol. 4, no. 3, 2022, pp. 106-111. https://doi.org/10.18231/j.ijrimcr.2022.026
Chicago
K, N., C, M., K, S., RT, S.. "Epidemiology of Endometrial Cancer at a Tertiary Cancer Hospital, Hyderabad." Int J Recent Innov Med Clin Res 4, no. 3 (2022): 106-111. https://doi.org/10.18231/j.ijrimcr.2022.026